Distinct Regulation of CXCL10 Production by Cytokines in Human Salivary Gland Ductal and Acinar Cells

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Inflammation

• Publication date

  2018-03-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10753-018-0764-0PMID 29549479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome

  2015cited by this paper
• Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons

  2015cited by this paper
• Targeting IL-1 in Sjögren's syndrome

  2013cited by this paper
• Advances in understanding the pathogenesis of primary Sjögren's syndrome

  2013cited by this paper
• CXCR3 ligands: redundant, collaborative and antagonistic functions

  2011influential reference
• TNFα-exposed Bone Marrow-derived Mesenchymal Stem Cells Promote Locomotion of MDA-MB-231 Breast Cancer Cells through Transcriptional Activation of CXCR3 Ligand Chemokines*

  2010cited by this paper
• Essential involvement of cross‐talk between IFN‐γ and TNF‐α in CXCL10 production in human THP‐1 monocytes

  2009cited by this paper
• Gene expression and chromosomal location for susceptibility to Sjögren's syndrome.

  2009cited by this paper
• Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.

  2006cited by this paper
• Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

  2005cited by this paper
• Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome.

  2004cited by this paper
• High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis

  2003cited by this paper
• Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.

  2002cited by this paper
• Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.

  2001cited by this paper
• Chemokines in autoimmune disease.

  2001cited by this paper
• Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription

  2001cited by this paper
• Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription.

  2001cited by this paper
• Chemokine receptors and their role in inflammation and infectious diseases.

  2000cited by this paper
• CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis.

  2000cited by this paper
• Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.

  1998cited by this paper
• p48/STAT-1α-Containing Complexes Play a Predominant Role in Induction of IFN-γ-Inducible Protein, 10 kDa (IP-10) by IFN-γ Alone or in Synergy with TNF-α

  1998influential reference
• p48/STAT-1alpha-containing complexes play a predominant role in induction of IFN-gamma-inducible protein, 10 kDa (IP-10) by IFN-gamma alone or in synergy with TNF-alpha.

  1998cited by this paper
• Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo*

  1997influential reference
• The IFN gamma receptor: a paradigm for cytokine receptor signaling.

  1997cited by this paper
• Chemokines: leucocyte recruitment and activation cytokines.

  1997cited by this paper
• Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.

  1997cited by this paper
• Lymphotactin: a cytokine that represents a new class of chemokine.

  1994cited by this paper
• Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.

  1994influential reference
• Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori- mutant deoxyribonucleic acid.

  1993cited by this paper
• Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences.

  1990cited by this paper
• Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases.

  1984cited by this paper
• Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies.

  1983cited by this paper

• Replication of human enteric viruses from wastewater in saliva cell lines.

  2025cites this paper
• Post-genome-wide association study dissects genetic vulnerability and risk gene expression of Sjögren’s disease for cardiovascular disease

  2025cites this paper
• Establishment of immortalized human minor salivary gland cells and chemokine expression induced by IFN-γ, TNF-α, and IL-1β

  2025cites this paper
• Characteristic TARC/CCL17 expression in the salivary gland of IgG4-related disease: potential diagnostic utility and insights into pathogenesis

  2025cites this paper
• Activation of Janus kinase 2 contributes to the autoimmune pathology in the salivary glands of patients with Sjögren's syndrome

  2024cites this paper
• Chemokines and lymphocyte homing in Sjögren’s syndrome

  2024cites this paper
• Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10

  2024cites this paper
• Time-course analysis of antibody and cytokine response after the third SARS-CoV-2 vaccine dose

  2024cites this paper
• Role of chemokines CXCL9, CXCL10, CXCL11, and CXCR3 in the serum and minor salivary gland tissues of patients with Sjögren’s syndrome

  2024cites this paper
• Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome

  2023cites this paper
• Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus.

  2023cites this paper
• Sexual health in women with Sjogren's syndrome: A review.

  2023cites this paper
• Ruscogenin Ameliorated Sjögren's Syndrome by Inhibiting NLRP3 Inflammasome Activation

  2022cites this paper
• The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis

  2022cites this paper
• IFN-γ, should not be ignored in SLE

  2022cites this paper
• Study on the polarization pathways of macrophages and related diseases

  2022cites this paper
• Extracellular Adenosine Diphosphate Stimulates CXCL10-Mediated Mast Cell Infiltration Through P2Y1 Receptor to Aggravate Airway Inflammation in Asthmatic Mice

  2021cites this paper
• Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37

  2020cites this paper
• Vaginal dryness in primary Sjögren’s syndrome: a histopathological case–control study

  2020cites this paper
• Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells

  2020cites this paper
• Sjögren's syndrome : Challenges of a multifaceted disease

  2020cites this paper
• Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells

  2020cites this paper
• MMP-9 Inhibition Suppresses Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells

  2019cites this paper